nodes	percent_of_prediction	percent_of_DWPC	metapath
Pazopanib—MAP3K9—telencephalon—autistic disorder	0.00612	0.0147	CbGeAlD
Pazopanib—LIMK2—mouth—autistic disorder	0.00543	0.013	CbGeAlD
Pazopanib—TAOK1—eye—autistic disorder	0.00504	0.0121	CbGeAlD
Pazopanib—TAOK1—forebrain—autistic disorder	0.005	0.012	CbGeAlD
Pazopanib—FGF1—hindbrain—autistic disorder	0.00494	0.0119	CbGeAlD
Pazopanib—SH2B3—eye—autistic disorder	0.00475	0.0114	CbGeAlD
Pazopanib—MAP3K9—digestive system—autistic disorder	0.00467	0.0112	CbGeAlD
Pazopanib—FGFR2—hindbrain—autistic disorder	0.00466	0.0112	CbGeAlD
Pazopanib—TAOK1—telencephalon—autistic disorder	0.0046	0.011	CbGeAlD
Pazopanib—FGF1—mouth—autistic disorder	0.00433	0.0104	CbGeAlD
Pazopanib—SH2B3—telencephalon—autistic disorder	0.00433	0.0104	CbGeAlD
Pazopanib—FGFR2—mouth—autistic disorder	0.00409	0.00982	CbGeAlD
Pazopanib—TAOK3—hindbrain—autistic disorder	0.00407	0.00978	CbGeAlD
Pazopanib—FGFR3—forebrain—autistic disorder	0.00394	0.00946	CbGeAlD
Pazopanib—MAP3K9—head—autistic disorder	0.00381	0.00916	CbGeAlD
Pazopanib—MAP2K5—hindbrain—autistic disorder	0.00365	0.00877	CbGeAlD
Pazopanib—FGFR3—telencephalon—autistic disorder	0.00362	0.0087	CbGeAlD
Pazopanib—MAP3K9—nervous system—autistic disorder	0.00361	0.00868	CbGeAlD
Pazopanib—MAP3K9—central nervous system—autistic disorder	0.00348	0.00836	CbGeAlD
Pazopanib—MAP3K9—cerebellum—autistic disorder	0.0034	0.00817	CbGeAlD
Pazopanib—KIT—hindbrain—autistic disorder	0.00324	0.00777	CbGeAlD
Pazopanib—PI4KB—telencephalon—autistic disorder	0.0032	0.00769	CbGeAlD
Pazopanib—FLT4—eye—autistic disorder	0.0031	0.00745	CbGeAlD
Pazopanib—TAOK1—head—autistic disorder	0.00286	0.00687	CbGeAlD
Pazopanib—KIT—mouth—autistic disorder	0.00284	0.00682	CbGeAlD
Pazopanib—FGF1—brainstem—autistic disorder	0.00283	0.00679	CbGeAlD
Pazopanib—PIP4K2C—telencephalon—autistic disorder	0.00281	0.00675	CbGeAlD
Pazopanib—STK16—digestive system—autistic disorder	0.00281	0.00675	CbGeAlD
Pazopanib—FGFR1—telencephalon—autistic disorder	0.00279	0.0067	CbGeAlD
Pazopanib—MAP3K9—brain—autistic disorder	0.00276	0.00663	CbGeAlD
Pazopanib—FGF1—eye—autistic disorder	0.00275	0.00661	CbGeAlD
Pazopanib—FGF1—forebrain—autistic disorder	0.00273	0.00656	CbGeAlD
Pazopanib—TAOK1—nervous system—autistic disorder	0.00271	0.00652	CbGeAlD
Pazopanib—SH2B3—head—autistic disorder	0.00269	0.00647	CbGeAlD
Pazopanib—FGFR2—brainstem—autistic disorder	0.00267	0.00642	CbGeAlD
Pazopanib—MAP3K2—telencephalon—autistic disorder	0.00267	0.0064	CbGeAlD
Pazopanib—AURKC—head—autistic disorder	0.00265	0.00637	CbGeAlD
Pazopanib—TAOK1—central nervous system—autistic disorder	0.00261	0.00627	CbGeAlD
Pazopanib—FGFR2—eye—autistic disorder	0.0026	0.00625	CbGeAlD
Pazopanib—FGFR2—forebrain—autistic disorder	0.00258	0.00619	CbGeAlD
Pazopanib—SH2B3—nervous system—autistic disorder	0.00255	0.00614	CbGeAlD
Pazopanib—TAOK1—cerebellum—autistic disorder	0.00255	0.00613	CbGeAlD
Pazopanib—AURKC—nervous system—autistic disorder	0.00252	0.00604	CbGeAlD
Pazopanib—FGF1—telencephalon—autistic disorder	0.00251	0.00603	CbGeAlD
Pazopanib—SH2B3—central nervous system—autistic disorder	0.00246	0.00591	CbGeAlD
Pazopanib—AURKC—central nervous system—autistic disorder	0.00242	0.00581	CbGeAlD
Pazopanib—FLT1—eye—autistic disorder	0.00241	0.00579	CbGeAlD
Pazopanib—SH2B3—cerebellum—autistic disorder	0.0024	0.00577	CbGeAlD
Pazopanib—FGFR2—telencephalon—autistic disorder	0.00237	0.00569	CbGeAlD
Pazopanib—EPHB6—forebrain—autistic disorder	0.00236	0.00567	CbGeAlD
Pazopanib—TAOK3—brainstem—autistic disorder	0.00234	0.00561	CbGeAlD
Pazopanib—STK16—head—autistic disorder	0.00229	0.0055	CbGeAlD
Pazopanib—TAOK3—eye—autistic disorder	0.00227	0.00546	CbGeAlD
Pazopanib—LYN—head—autistic disorder	0.00227	0.00544	CbGeAlD
Pazopanib—RIOK2—head—autistic disorder	0.00226	0.00542	CbGeAlD
Pazopanib—FGFR3—head—autistic disorder	0.00226	0.00542	CbGeAlD
Pazopanib—TAOK3—forebrain—autistic disorder	0.00225	0.00541	CbGeAlD
Pazopanib—PDGFRA—forebrain—autistic disorder	0.00224	0.00538	CbGeAlD
Pazopanib—MAP3K19—head—autistic disorder	0.00223	0.00536	CbGeAlD
Pazopanib—BMPR1B—head—autistic disorder	0.00223	0.00536	CbGeAlD
Pazopanib—FLT1—telencephalon—autistic disorder	0.0022	0.00528	CbGeAlD
Pazopanib—EPHB6—telencephalon—autistic disorder	0.00217	0.00522	CbGeAlD
Pazopanib—STK16—nervous system—autistic disorder	0.00217	0.00522	CbGeAlD
Pazopanib—LYN—nervous system—autistic disorder	0.00215	0.00516	CbGeAlD
Pazopanib—FGFR3—nervous system—autistic disorder	0.00214	0.00514	CbGeAlD
Pazopanib—RIOK2—nervous system—autistic disorder	0.00214	0.00514	CbGeAlD
Pazopanib—MAP3K19—nervous system—autistic disorder	0.00212	0.00508	CbGeAlD
Pazopanib—BMPR1B—nervous system—autistic disorder	0.00212	0.00508	CbGeAlD
Pazopanib—MAP2K5—brainstem—autistic disorder	0.00209	0.00503	CbGeAlD
Pazopanib—STK16—central nervous system—autistic disorder	0.00209	0.00502	CbGeAlD
Pazopanib—TAOK1—brain—autistic disorder	0.00207	0.00498	CbGeAlD
Pazopanib—TAOK3—telencephalon—autistic disorder	0.00207	0.00498	CbGeAlD
Pazopanib—LYN—central nervous system—autistic disorder	0.00207	0.00497	CbGeAlD
Pazopanib—PDGFRA—telencephalon—autistic disorder	0.00206	0.00495	CbGeAlD
Pazopanib—RIOK2—central nervous system—autistic disorder	0.00206	0.00494	CbGeAlD
Pazopanib—FGFR3—central nervous system—autistic disorder	0.00206	0.00494	CbGeAlD
Pazopanib—STK16—cerebellum—autistic disorder	0.00204	0.00491	CbGeAlD
Pazopanib—MAP3K19—central nervous system—autistic disorder	0.00204	0.00489	CbGeAlD
Pazopanib—BMPR1B—central nervous system—autistic disorder	0.00204	0.00489	CbGeAlD
Pazopanib—KDR—eye—autistic disorder	0.00204	0.00489	CbGeAlD
Pazopanib—STK36—head—autistic disorder	0.00203	0.00487	CbGeAlD
Pazopanib—KDR—forebrain—autistic disorder	0.00202	0.00485	CbGeAlD
Pazopanib—RIOK2—cerebellum—autistic disorder	0.00201	0.00483	CbGeAlD
Pazopanib—FGFR3—cerebellum—autistic disorder	0.00201	0.00483	CbGeAlD
Pazopanib—PI4KB—head—autistic disorder	0.002	0.00479	CbGeAlD
Pazopanib—BMPR1B—cerebellum—autistic disorder	0.00199	0.00478	CbGeAlD
Pazopanib—CSF1R—eye—autistic disorder	0.00199	0.00478	CbGeAlD
Pazopanib—CSF1R—forebrain—autistic disorder	0.00197	0.00474	CbGeAlD
Pazopanib—LIMK2—head—autistic disorder	0.00196	0.0047	CbGeAlD
Pazopanib—SH2B3—brain—autistic disorder	0.00195	0.00469	CbGeAlD
Pazopanib—AURKC—brain—autistic disorder	0.00192	0.00462	CbGeAlD
Pazopanib—STK36—nervous system—autistic disorder	0.00192	0.00461	CbGeAlD
Pazopanib—FGF1—digestive system—autistic disorder	0.00192	0.0046	CbGeAlD
Pazopanib—PI4KB—nervous system—autistic disorder	0.00189	0.00454	CbGeAlD
Pazopanib—MAP2K5—telencephalon—autistic disorder	0.00186	0.00446	CbGeAlD
Pazopanib—LIMK2—nervous system—autistic disorder	0.00186	0.00446	CbGeAlD
Pazopanib—KIT—brainstem—autistic disorder	0.00186	0.00446	CbGeAlD
Pazopanib—STK36—central nervous system—autistic disorder	0.00185	0.00444	CbGeAlD
Pazopanib—PI4KB—central nervous system—autistic disorder	0.00182	0.00437	CbGeAlD
Pazopanib—CSF1R—telencephalon—autistic disorder	0.00181	0.00435	CbGeAlD
Pazopanib—FGFR2—digestive system—autistic disorder	0.00181	0.00435	CbGeAlD
Pazopanib—STK36—cerebellum—autistic disorder	0.00181	0.00434	CbGeAlD
Pazopanib—LIMK2—central nervous system—autistic disorder	0.00179	0.00429	CbGeAlD
Pazopanib—PI4KB—cerebellum—autistic disorder	0.00178	0.00427	CbGeAlD
Pazopanib—PDGFRB—eye—autistic disorder	0.00176	0.00424	CbGeAlD
Pazopanib—FLT4—head—autistic disorder	0.00176	0.00423	CbGeAlD
Pazopanib—PLK4—brain—autistic disorder	0.00176	0.00422	CbGeAlD
Pazopanib—PIP4K2C—head—autistic disorder	0.00175	0.0042	CbGeAlD
Pazopanib—LIMK2—cerebellum—autistic disorder	0.00175	0.0042	CbGeAlD
Pazopanib—FLT1—digestive system—autistic disorder	0.00168	0.00403	CbGeAlD
Pazopanib—STK16—brain—autistic disorder	0.00166	0.00399	CbGeAlD
Pazopanib—PIP4K2C—nervous system—autistic disorder	0.00166	0.00399	CbGeAlD
Pazopanib—MAP3K2—head—autistic disorder	0.00166	0.00399	CbGeAlD
Pazopanib—KIT—telencephalon—autistic disorder	0.00165	0.00395	CbGeAlD
Pazopanib—LYN—brain—autistic disorder	0.00164	0.00395	CbGeAlD
Pazopanib—FGFR3—brain—autistic disorder	0.00163	0.00393	CbGeAlD
Pazopanib—RIOK2—brain—autistic disorder	0.00163	0.00393	CbGeAlD
Pazopanib—MAP3K19—brain—autistic disorder	0.00162	0.00389	CbGeAlD
Pazopanib—BMPR1B—brain—autistic disorder	0.00162	0.00389	CbGeAlD
Pazopanib—PDGFRB—telencephalon—autistic disorder	0.00161	0.00386	CbGeAlD
Pazopanib—PIP4K2C—central nervous system—autistic disorder	0.0016	0.00384	CbGeAlD
Pazopanib—STK10—digestive system—autistic disorder	0.00159	0.00381	CbGeAlD
Pazopanib—TAOK3—digestive system—autistic disorder	0.00158	0.0038	CbGeAlD
Pazopanib—MAP3K2—nervous system—autistic disorder	0.00157	0.00378	CbGeAlD
Pazopanib—PDGFRA—digestive system—autistic disorder	0.00157	0.00378	CbGeAlD
Pazopanib—FGF1—head—autistic disorder	0.00156	0.00375	CbGeAlD
Pazopanib—PIP4K2C—cerebellum—autistic disorder	0.00156	0.00375	CbGeAlD
Pazopanib—FGFR1—cerebellum—autistic disorder	0.00155	0.00372	CbGeAlD
Pazopanib—MAP3K2—central nervous system—autistic disorder	0.00151	0.00364	CbGeAlD
Pazopanib—UGT1A1—digestive system—autistic disorder	0.0015	0.0036	CbGeAlD
Pazopanib—FGF1—nervous system—autistic disorder	0.00148	0.00356	CbGeAlD
Pazopanib—MAP3K2—cerebellum—autistic disorder	0.00148	0.00356	CbGeAlD
Pazopanib—FGFR2—head—autistic disorder	0.00148	0.00355	CbGeAlD
Pazopanib—STK36—brain—autistic disorder	0.00147	0.00353	CbGeAlD
Pazopanib—PI4KB—brain—autistic disorder	0.00145	0.00347	CbGeAlD
Pazopanib—FGF1—central nervous system—autistic disorder	0.00143	0.00343	CbGeAlD
Pazopanib—LIMK2—brain—autistic disorder	0.00142	0.00341	CbGeAlD
Pazopanib—KDR—digestive system—autistic disorder	0.00142	0.00341	CbGeAlD
Pazopanib—FGFR2—nervous system—autistic disorder	0.0014	0.00336	CbGeAlD
Pazopanib—FGF1—cerebellum—autistic disorder	0.00139	0.00335	CbGeAlD
Pazopanib—CSF1R—digestive system—autistic disorder	0.00138	0.00332	CbGeAlD
Pazopanib—FLT1—head—autistic disorder	0.00137	0.00329	CbGeAlD
Pazopanib—EPHB6—head—autistic disorder	0.00135	0.00325	CbGeAlD
Pazopanib—FGFR2—central nervous system—autistic disorder	0.00135	0.00324	CbGeAlD
Pazopanib—FGFR2—cerebellum—autistic disorder	0.00132	0.00316	CbGeAlD
Pazopanib—FLT1—nervous system—autistic disorder	0.0013	0.00312	CbGeAlD
Pazopanib—STK10—head—autistic disorder	0.0013	0.00311	CbGeAlD
Pazopanib—TAOK3—head—autistic disorder	0.00129	0.0031	CbGeAlD
Pazopanib—EPHB6—nervous system—autistic disorder	0.00128	0.00308	CbGeAlD
Pazopanib—PDGFRA—head—autistic disorder	0.00128	0.00308	CbGeAlD
Pazopanib—FLT4—brain—autistic disorder	0.00128	0.00306	CbGeAlD
Pazopanib—PIP4K2C—brain—autistic disorder	0.00127	0.00305	CbGeAlD
Pazopanib—FGFR1—brain—autistic disorder	0.00126	0.00302	CbGeAlD
Pazopanib—KIT—digestive system—autistic disorder	0.00126	0.00302	CbGeAlD
Pazopanib—FLT1—central nervous system—autistic disorder	0.00125	0.003	CbGeAlD
Pazopanib—SLCO1B1—digestive system—autistic disorder	0.00125	0.003	CbGeAlD
Pazopanib—EPHB6—central nervous system—autistic disorder	0.00123	0.00297	CbGeAlD
Pazopanib—STK10—nervous system—autistic disorder	0.00123	0.00295	CbGeAlD
Pazopanib—PDGFRB—digestive system—autistic disorder	0.00123	0.00295	CbGeAlD
Pazopanib—TAOK3—nervous system—autistic disorder	0.00122	0.00294	CbGeAlD
Pazopanib—FLT1—cerebellum—autistic disorder	0.00122	0.00293	CbGeAlD
Pazopanib—CYP2D6—hindbrain—autistic disorder	0.00122	0.00293	CbGeAlD
Pazopanib—PDGFRA—nervous system—autistic disorder	0.00122	0.00292	CbGeAlD
Pazopanib—EPHB6—cerebellum—autistic disorder	0.00121	0.0029	CbGeAlD
Pazopanib—MAP3K2—brain—autistic disorder	0.0012	0.00289	CbGeAlD
Pazopanib—STK10—central nervous system—autistic disorder	0.00118	0.00284	CbGeAlD
Pazopanib—TAOK3—central nervous system—autistic disorder	0.00118	0.00283	CbGeAlD
Pazopanib—PDGFRA—central nervous system—autistic disorder	0.00117	0.00281	CbGeAlD
Pazopanib—KDR—head—autistic disorder	0.00116	0.00278	CbGeAlD
Pazopanib—MAP2K5—head—autistic disorder	0.00116	0.00278	CbGeAlD
Pazopanib—STK10—cerebellum—autistic disorder	0.00116	0.00278	CbGeAlD
Pazopanib—TAOK3—cerebellum—autistic disorder	0.00115	0.00276	CbGeAlD
Pazopanib—PDGFRA—cerebellum—autistic disorder	0.00114	0.00275	CbGeAlD
Pazopanib—FGF1—brain—autistic disorder	0.00113	0.00272	CbGeAlD
Pazopanib—CSF1R—head—autistic disorder	0.00113	0.00271	CbGeAlD
Pazopanib—KDR—nervous system—autistic disorder	0.0011	0.00263	CbGeAlD
Pazopanib—MAP2K5—nervous system—autistic disorder	0.0011	0.00263	CbGeAlD
Pazopanib—CSF1R—nervous system—autistic disorder	0.00107	0.00257	CbGeAlD
Pazopanib—FGFR2—brain—autistic disorder	0.00107	0.00257	CbGeAlD
Pazopanib—KDR—central nervous system—autistic disorder	0.00106	0.00254	CbGeAlD
Pazopanib—MAP2K5—central nervous system—autistic disorder	0.00106	0.00254	CbGeAlD
Pazopanib—KDR—cerebellum—autistic disorder	0.00103	0.00248	CbGeAlD
Pazopanib—MAP2K5—cerebellum—autistic disorder	0.00103	0.00248	CbGeAlD
Pazopanib—CSF1R—central nervous system—autistic disorder	0.00103	0.00247	CbGeAlD
Pazopanib—KIT—head—autistic disorder	0.00103	0.00246	CbGeAlD
Pazopanib—CSF1R—cerebellum—autistic disorder	0.00101	0.00242	CbGeAlD
Pazopanib—PDGFRB—head—autistic disorder	0.001	0.0024	CbGeAlD
Pazopanib—FLT1—brain—autistic disorder	0.000992	0.00238	CbGeAlD
Pazopanib—EPHB6—brain—autistic disorder	0.00098	0.00235	CbGeAlD
Pazopanib—KIT—nervous system—autistic disorder	0.000972	0.00233	CbGeAlD
Pazopanib—PDGFRB—nervous system—autistic disorder	0.000949	0.00228	CbGeAlD
Pazopanib—STK10—brain—autistic disorder	0.000939	0.00225	CbGeAlD
Pazopanib—KIT—central nervous system—autistic disorder	0.000936	0.00225	CbGeAlD
Pazopanib—TAOK3—brain—autistic disorder	0.000935	0.00225	CbGeAlD
Pazopanib—PDGFRA—brain—autistic disorder	0.000929	0.00223	CbGeAlD
Pazopanib—KIT—cerebellum—autistic disorder	0.000915	0.0022	CbGeAlD
Pazopanib—PDGFRB—central nervous system—autistic disorder	0.000914	0.00219	CbGeAlD
Pazopanib—ABCG2—telencephalon—autistic disorder	0.000904	0.00217	CbGeAlD
Pazopanib—PDGFRB—cerebellum—autistic disorder	0.000893	0.00215	CbGeAlD
Pazopanib—KDR—brain—autistic disorder	0.000838	0.00201	CbGeAlD
Pazopanib—MAP2K5—brain—autistic disorder	0.000838	0.00201	CbGeAlD
Pazopanib—CSF1R—brain—autistic disorder	0.000818	0.00196	CbGeAlD
Pazopanib—KIT—brain—autistic disorder	0.000743	0.00178	CbGeAlD
Pazopanib—PDGFRB—brain—autistic disorder	0.000726	0.00174	CbGeAlD
Pazopanib—CYP2D6—brainstem—autistic disorder	0.000698	0.00168	CbGeAlD
Pazopanib—CYP2D6—forebrain—autistic disorder	0.000674	0.00162	CbGeAlD
Pazopanib—CYP1A2—digestive system—autistic disorder	0.000664	0.00159	CbGeAlD
Pazopanib—CYP2D6—telencephalon—autistic disorder	0.00062	0.00149	CbGeAlD
Pazopanib—ABCG2—cerebellum—autistic disorder	0.000502	0.00121	CbGeAlD
Pazopanib—ABCB1—forebrain—autistic disorder	0.000485	0.00116	CbGeAlD
Pazopanib—CYP3A4—digestive system—autistic disorder	0.000481	0.00115	CbGeAlD
Pazopanib—CYP2D6—digestive system—autistic disorder	0.000473	0.00114	CbGeAlD
Pazopanib—ABCB1—telencephalon—autistic disorder	0.000446	0.00107	CbGeAlD
Pazopanib—CYP2C8—brain—autistic disorder	0.000419	0.00101	CbGeAlD
Pazopanib—ABCG2—brain—autistic disorder	0.000408	0.000979	CbGeAlD
Pazopanib—CYP2D6—head—autistic disorder	0.000386	0.000927	CbGeAlD
Pazopanib—CYP3A4—nervous system—autistic disorder	0.000372	0.000893	CbGeAlD
Pazopanib—CYP2D6—nervous system—autistic disorder	0.000366	0.000878	CbGeAlD
Pazopanib—CYP3A4—central nervous system—autistic disorder	0.000358	0.000859	CbGeAlD
Pazopanib—CYP2D6—central nervous system—autistic disorder	0.000352	0.000846	CbGeAlD
Pazopanib—CYP2D6—cerebellum—autistic disorder	0.000344	0.000827	CbGeAlD
Pazopanib—ABCB1—digestive system—autistic disorder	0.00034	0.000817	CbGeAlD
Pazopanib—CYP2D6—brain—autistic disorder	0.00028	0.000671	CbGeAlD
Pazopanib—ABCB1—head—autistic disorder	0.000278	0.000666	CbGeAlD
Pazopanib—ABCB1—nervous system—autistic disorder	0.000263	0.000632	CbGeAlD
Pazopanib—ABCB1—central nervous system—autistic disorder	0.000253	0.000608	CbGeAlD
Pazopanib—ABCB1—cerebellum—autistic disorder	0.000248	0.000595	CbGeAlD
Pazopanib—ABCB1—brain—autistic disorder	0.000201	0.000483	CbGeAlD
Pazopanib—CYP1A2—Metabolism—MAOB—autistic disorder	1.04e-05	1.79e-05	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—XDH—autistic disorder	1.04e-05	1.79e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—PRKCB—autistic disorder	1.04e-05	1.78e-05	CbGpPWpGaD
Pazopanib—UGT1A1—Metabolism—POMC—autistic disorder	1.04e-05	1.78e-05	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—SERPINE1—autistic disorder	1.03e-05	1.77e-05	CbGpPWpGaD
Pazopanib—ABCG2—Metabolism—APOE—autistic disorder	1.02e-05	1.76e-05	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—STX1A—autistic disorder	1.02e-05	1.75e-05	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—NPAS2—autistic disorder	1.02e-05	1.75e-05	CbGpPWpGaD
Pazopanib—MAP2K5—Signaling Pathways—PTEN—autistic disorder	1.02e-05	1.75e-05	CbGpPWpGaD
Pazopanib—FGFR3—Disease—IL6—autistic disorder	1.02e-05	1.75e-05	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—ITGB3—autistic disorder	1.02e-05	1.75e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Immune System—PTEN—autistic disorder	1.02e-05	1.75e-05	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—PRKCB—autistic disorder	1.02e-05	1.74e-05	CbGpPWpGaD
Pazopanib—LCK—Hemostasis—HRAS—autistic disorder	1.02e-05	1.74e-05	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—SERPINE1—autistic disorder	1.01e-05	1.74e-05	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—IGF1—autistic disorder	1.01e-05	1.74e-05	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—DHFR—autistic disorder	1.01e-05	1.73e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—IGF1—autistic disorder	1.01e-05	1.73e-05	CbGpPWpGaD
Pazopanib—FGF1—Signaling Pathways—IL2—autistic disorder	1.01e-05	1.73e-05	CbGpPWpGaD
Pazopanib—SLCO1B1—Metabolism—PIK3CG—autistic disorder	9.99e-06	1.71e-05	CbGpPWpGaD
Pazopanib—LYN—Immune System—PTEN—autistic disorder	9.98e-06	1.71e-05	CbGpPWpGaD
Pazopanib—KDR—Signaling Pathways—PTEN—autistic disorder	9.96e-06	1.71e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—APC—autistic disorder	9.95e-06	1.7e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—PIK3CG—autistic disorder	9.95e-06	1.7e-05	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism of lipids and lipoproteins—APOE—autistic disorder	9.93e-06	1.7e-05	CbGpPWpGaD
Pazopanib—LCK—Disease—SERPINE1—autistic disorder	9.91e-06	1.7e-05	CbGpPWpGaD
Pazopanib—FGFR2—Immune System—MAPK1—autistic disorder	9.89e-06	1.69e-05	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—TCN2—autistic disorder	9.88e-06	1.69e-05	CbGpPWpGaD
Pazopanib—LCK—Immune System—BCL2—autistic disorder	9.87e-06	1.69e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—EGF—autistic disorder	9.83e-06	1.69e-05	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—autistic disorder	9.79e-06	1.68e-05	CbGpPWpGaD
Pazopanib—LCK—Immune System—IFNG—autistic disorder	9.78e-06	1.68e-05	CbGpPWpGaD
Pazopanib—FLT1—Signaling Pathways—HRAS—autistic disorder	9.77e-06	1.67e-05	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—APC—autistic disorder	9.74e-06	1.67e-05	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—PIK3CG—autistic disorder	9.74e-06	1.67e-05	CbGpPWpGaD
Pazopanib—KIT—Immune System—MAPK1—autistic disorder	9.71e-06	1.66e-05	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—TPH2—autistic disorder	9.7e-06	1.66e-05	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—EGF—autistic disorder	9.63e-06	1.65e-05	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—SERPINE1—autistic disorder	9.63e-06	1.65e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—SERPINE1—autistic disorder	9.6e-06	1.65e-05	CbGpPWpGaD
Pazopanib—FGF1—Immune System—HRAS—autistic disorder	9.59e-06	1.64e-05	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—DPYD—autistic disorder	9.55e-06	1.64e-05	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—DHFR—autistic disorder	9.53e-06	1.63e-05	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—HTR2A—autistic disorder	9.52e-06	1.63e-05	CbGpPWpGaD
Pazopanib—SLCO1B1—Metabolism—POMC—autistic disorder	9.51e-06	1.63e-05	CbGpPWpGaD
Pazopanib—FGF1—Signaling Pathways—PTEN—autistic disorder	9.5e-06	1.63e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—POMC—autistic disorder	9.47e-06	1.62e-05	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—ADA—autistic disorder	9.43e-06	1.62e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Disease—PTEN—autistic disorder	9.41e-06	1.61e-05	CbGpPWpGaD
Pazopanib—FLT1—Signaling Pathways—IL6—autistic disorder	9.35e-06	1.6e-05	CbGpPWpGaD
Pazopanib—FGFR3—Signaling Pathways—MAPK1—autistic disorder	9.3e-06	1.59e-05	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—POMC—autistic disorder	9.27e-06	1.59e-05	CbGpPWpGaD
Pazopanib—ABCG2—Metabolism—PIK3CG—autistic disorder	9.25e-06	1.59e-05	CbGpPWpGaD
Pazopanib—FGFR1—Immune System—MAPK1—autistic disorder	9.22e-06	1.58e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Immune System—MAPK1—autistic disorder	9.19e-06	1.58e-05	CbGpPWpGaD
Pazopanib—FGF1—Immune System—IL6—autistic disorder	9.18e-06	1.57e-05	CbGpPWpGaD
Pazopanib—LCK—Innate Immune System—HRAS—autistic disorder	9.16e-06	1.57e-05	CbGpPWpGaD
Pazopanib—FGFR2—Disease—MAPK1—autistic disorder	9.13e-06	1.56e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—IGF1—autistic disorder	9.11e-06	1.56e-05	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—CYP19A1—autistic disorder	9.09e-06	1.56e-05	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—TSC2—autistic disorder	9.04e-06	1.55e-05	CbGpPWpGaD
Pazopanib—KIT—Disease—MAPK1—autistic disorder	8.97e-06	1.54e-05	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—autistic disorder	8.96e-06	1.54e-05	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—IGF1—autistic disorder	8.92e-06	1.53e-05	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—CACNA1C—autistic disorder	8.87e-06	1.52e-05	CbGpPWpGaD
Pazopanib—FGF1—Disease—HRAS—autistic disorder	8.86e-06	1.52e-05	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—APOE—autistic disorder	8.85e-06	1.52e-05	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—LEP—autistic disorder	8.85e-06	1.52e-05	CbGpPWpGaD
Pazopanib—ABCG2—Metabolism—POMC—autistic disorder	8.8e-06	1.51e-05	CbGpPWpGaD
Pazopanib—LCK—Adaptive Immune System—HRAS—autistic disorder	8.8e-06	1.51e-05	CbGpPWpGaD
Pazopanib—LCK—Innate Immune System—IL6—autistic disorder	8.77e-06	1.5e-05	CbGpPWpGaD
Pazopanib—LCK—Immune System—IL2—autistic disorder	8.69e-06	1.49e-05	CbGpPWpGaD
Pazopanib—LCK—Disease—PTGS2—autistic disorder	8.66e-06	1.48e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—SERPINE1—autistic disorder	8.65e-06	1.48e-05	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—RORA—autistic disorder	8.6e-06	1.47e-05	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—autistic disorder	8.53e-06	1.46e-05	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism of lipids and lipoproteins—POMC—autistic disorder	8.53e-06	1.46e-05	CbGpPWpGaD
Pazopanib—FGFR1—Disease—MAPK1—autistic disorder	8.51e-06	1.46e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Disease—MAPK1—autistic disorder	8.49e-06	1.45e-05	CbGpPWpGaD
Pazopanib—FGF1—Disease—IL6—autistic disorder	8.48e-06	1.45e-05	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—SERPINE1—autistic disorder	8.47e-06	1.45e-05	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—COMT—autistic disorder	8.45e-06	1.45e-05	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—GSTP1—autistic disorder	8.41e-06	1.44e-05	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—MAOA—autistic disorder	8.39e-06	1.44e-05	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—IL2—autistic disorder	8.36e-06	1.43e-05	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—PRKCB—autistic disorder	8.34e-06	1.43e-05	CbGpPWpGaD
Pazopanib—MAP2K5—Signaling Pathways—MAPK1—autistic disorder	8.31e-06	1.42e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Immune System—MAPK1—autistic disorder	8.28e-06	1.42e-05	CbGpPWpGaD
Pazopanib—UGT1A1—Metabolism—PTGS2—autistic disorder	8.28e-06	1.42e-05	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—IL2—autistic disorder	8.21e-06	1.41e-05	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—CAT—autistic disorder	8.19e-06	1.4e-05	CbGpPWpGaD
Pazopanib—LCK—Immune System—PTEN—autistic disorder	8.18e-06	1.4e-05	CbGpPWpGaD
Pazopanib—LYN—Immune System—MAPK1—autistic disorder	8.11e-06	1.39e-05	CbGpPWpGaD
Pazopanib—KDR—Signaling Pathways—MAPK1—autistic disorder	8.1e-06	1.39e-05	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—DHFR—autistic disorder	8.07e-06	1.38e-05	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—MAOB—autistic disorder	8.05e-06	1.38e-05	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—APC—autistic disorder	7.98e-06	1.37e-05	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—PIK3CG—autistic disorder	7.98e-06	1.37e-05	CbGpPWpGaD
Pazopanib—FGFR2—Immune System—HRAS—autistic disorder	7.94e-06	1.36e-05	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—CYP19A1—autistic disorder	7.92e-06	1.36e-05	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—EGF—autistic disorder	7.89e-06	1.35e-05	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—PTEN—autistic disorder	7.87e-06	1.35e-05	CbGpPWpGaD
Pazopanib—KIT—Immune System—HRAS—autistic disorder	7.8e-06	1.34e-05	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—IL2—autistic disorder	7.79e-06	1.34e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—IL2—autistic disorder	7.77e-06	1.33e-05	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—GSTM1—autistic disorder	7.73e-06	1.32e-05	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—PLA2G4A—autistic disorder	7.73e-06	1.32e-05	CbGpPWpGaD
Pazopanib—FGF1—Signaling Pathways—MAPK1—autistic disorder	7.73e-06	1.32e-05	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—PTEN—autistic disorder	7.72e-06	1.32e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Disease—MAPK1—autistic disorder	7.65e-06	1.31e-05	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—POMC—autistic disorder	7.6e-06	1.3e-05	CbGpPWpGaD
Pazopanib—FGFR2—Immune System—IL6—autistic disorder	7.6e-06	1.3e-05	CbGpPWpGaD
Pazopanib—SLCO1B1—Metabolism—PTGS2—autistic disorder	7.58e-06	1.3e-05	CbGpPWpGaD
Pazopanib—LCK—Disease—PTEN—autistic disorder	7.55e-06	1.29e-05	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—TPH2—autistic disorder	7.49e-06	1.28e-05	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—CYP19A1—autistic disorder	7.46e-06	1.28e-05	CbGpPWpGaD
Pazopanib—FGFR3—Signaling Pathways—HRAS—autistic disorder	7.46e-06	1.28e-05	CbGpPWpGaD
Pazopanib—KIT—Immune System—IL6—autistic disorder	7.46e-06	1.28e-05	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—GPX1—autistic disorder	7.4e-06	1.27e-05	CbGpPWpGaD
Pazopanib—FGFR1—Immune System—HRAS—autistic disorder	7.4e-06	1.27e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Immune System—HRAS—autistic disorder	7.38e-06	1.26e-05	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—DPYD—autistic disorder	7.37e-06	1.26e-05	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—COMT—autistic disorder	7.36e-06	1.26e-05	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—PTEN—autistic disorder	7.33e-06	1.26e-05	CbGpPWpGaD
Pazopanib—FGFR2—Disease—HRAS—autistic disorder	7.33e-06	1.26e-05	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—GSTP1—autistic disorder	7.33e-06	1.26e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—PTEN—autistic disorder	7.31e-06	1.25e-05	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—MAOA—autistic disorder	7.31e-06	1.25e-05	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—IGF1—autistic disorder	7.31e-06	1.25e-05	CbGpPWpGaD
Pazopanib—UGT1A1—Metabolism—PTEN—autistic disorder	7.22e-06	1.24e-05	CbGpPWpGaD
Pazopanib—KIT—Disease—HRAS—autistic disorder	7.2e-06	1.23e-05	CbGpPWpGaD
Pazopanib—FGFR3—Signaling Pathways—IL6—autistic disorder	7.14e-06	1.22e-05	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—CAT—autistic disorder	7.13e-06	1.22e-05	CbGpPWpGaD
Pazopanib—FGFR1—Immune System—IL6—autistic disorder	7.08e-06	1.21e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Immune System—IL6—autistic disorder	7.06e-06	1.21e-05	CbGpPWpGaD
Pazopanib—ABCG2—Metabolism—PTGS2—autistic disorder	7.02e-06	1.2e-05	CbGpPWpGaD
Pazopanib—FGFR2—Disease—IL6—autistic disorder	7.02e-06	1.2e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—IL2—autistic disorder	7e-06	1.2e-05	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—SERPINE1—autistic disorder	6.94e-06	1.19e-05	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—COMT—autistic disorder	6.94e-06	1.19e-05	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—GSTP1—autistic disorder	6.91e-06	1.18e-05	CbGpPWpGaD
Pazopanib—KIT—Disease—IL6—autistic disorder	6.89e-06	1.18e-05	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—MAOA—autistic disorder	6.89e-06	1.18e-05	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—IL2—autistic disorder	6.85e-06	1.17e-05	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—CACNA1C—autistic disorder	6.85e-06	1.17e-05	CbGpPWpGaD
Pazopanib—FGFR1—Disease—HRAS—autistic disorder	6.83e-06	1.17e-05	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—MTHFR—autistic disorder	6.83e-06	1.17e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Disease—HRAS—autistic disorder	6.82e-06	1.17e-05	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—autistic disorder	6.81e-06	1.17e-05	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—GSTM1—autistic disorder	6.73e-06	1.15e-05	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—PLA2G4A—autistic disorder	6.73e-06	1.15e-05	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—CAT—autistic disorder	6.72e-06	1.15e-05	CbGpPWpGaD
Pazopanib—MAP2K5—Signaling Pathways—HRAS—autistic disorder	6.67e-06	1.14e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Immune System—HRAS—autistic disorder	6.65e-06	1.14e-05	CbGpPWpGaD
Pazopanib—LCK—Immune System—MAPK1—autistic disorder	6.65e-06	1.14e-05	CbGpPWpGaD
Pazopanib—SLCO1B1—Metabolism—PTEN—autistic disorder	6.61e-06	1.13e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—PTEN—autistic disorder	6.59e-06	1.13e-05	CbGpPWpGaD
Pazopanib—FGFR1—Disease—IL6—autistic disorder	6.54e-06	1.12e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Disease—IL6—autistic disorder	6.52e-06	1.12e-05	CbGpPWpGaD
Pazopanib—LYN—Immune System—HRAS—autistic disorder	6.51e-06	1.12e-05	CbGpPWpGaD
Pazopanib—KDR—Signaling Pathways—HRAS—autistic disorder	6.5e-06	1.11e-05	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—GPX1—autistic disorder	6.45e-06	1.11e-05	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—PTEN—autistic disorder	6.45e-06	1.11e-05	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—MAPK1—autistic disorder	6.39e-06	1.1e-05	CbGpPWpGaD
Pazopanib—MAP2K5—Signaling Pathways—IL6—autistic disorder	6.39e-06	1.09e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Immune System—IL6—autistic disorder	6.36e-06	1.09e-05	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—APOE—autistic disorder	6.36e-06	1.09e-05	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—GSTM1—autistic disorder	6.35e-06	1.09e-05	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—PLA2G4A—autistic disorder	6.35e-06	1.09e-05	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—CYP19A1—autistic disorder	6.32e-06	1.08e-05	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—MAPK1—autistic disorder	6.28e-06	1.08e-05	CbGpPWpGaD
Pazopanib—LYN—Immune System—IL6—autistic disorder	6.23e-06	1.07e-05	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—DHFR—autistic disorder	6.23e-06	1.07e-05	CbGpPWpGaD
Pazopanib—KDR—Signaling Pathways—IL6—autistic disorder	6.22e-06	1.07e-05	CbGpPWpGaD
Pazopanib—FGF1—Signaling Pathways—HRAS—autistic disorder	6.2e-06	1.06e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Disease—HRAS—autistic disorder	6.14e-06	1.05e-05	CbGpPWpGaD
Pazopanib—LCK—Disease—MAPK1—autistic disorder	6.14e-06	1.05e-05	CbGpPWpGaD
Pazopanib—ABCG2—Metabolism—PTEN—autistic disorder	6.12e-06	1.05e-05	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—GPX1—autistic disorder	6.08e-06	1.04e-05	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—MAPK1—autistic disorder	5.96e-06	1.02e-05	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—MTHFR—autistic disorder	5.95e-06	1.02e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—MAPK1—autistic disorder	5.94e-06	1.02e-05	CbGpPWpGaD
Pazopanib—FGF1—Signaling Pathways—IL6—autistic disorder	5.94e-06	1.02e-05	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—autistic disorder	5.94e-06	1.02e-05	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—COMT—autistic disorder	5.88e-06	1.01e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Disease—IL6—autistic disorder	5.88e-06	1.01e-05	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—GSTP1—autistic disorder	5.85e-06	1e-05	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—MAOA—autistic disorder	5.84e-06	1e-05	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—PIK3CG—autistic disorder	5.74e-06	9.84e-06	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—CAT—autistic disorder	5.69e-06	9.76e-06	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—IL2—autistic disorder	5.62e-06	9.63e-06	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—MTHFR—autistic disorder	5.61e-06	9.61e-06	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—APOE—autistic disorder	5.54e-06	9.5e-06	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—POMC—autistic disorder	5.46e-06	9.36e-06	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—PLA2G4A—autistic disorder	5.38e-06	9.21e-06	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—GSTM1—autistic disorder	5.38e-06	9.21e-06	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—MAPK1—autistic disorder	5.36e-06	9.18e-06	CbGpPWpGaD
Pazopanib—LCK—Immune System—HRAS—autistic disorder	5.34e-06	9.14e-06	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—PTEN—autistic disorder	5.29e-06	9.06e-06	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—MAPK1—autistic disorder	5.24e-06	8.98e-06	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—APOE—autistic disorder	5.22e-06	8.95e-06	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—GPX1—autistic disorder	5.15e-06	8.82e-06	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—HRAS—autistic disorder	5.13e-06	8.8e-06	CbGpPWpGaD
Pazopanib—LCK—Immune System—IL6—autistic disorder	5.11e-06	8.75e-06	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—HRAS—autistic disorder	5.04e-06	8.64e-06	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—PIK3CG—autistic disorder	5e-06	8.57e-06	CbGpPWpGaD
Pazopanib—LCK—Disease—HRAS—autistic disorder	4.93e-06	8.44e-06	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—IL6—autistic disorder	4.91e-06	8.42e-06	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—CYP19A1—autistic disorder	4.88e-06	8.36e-06	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—IL6—autistic disorder	4.83e-06	8.27e-06	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—HRAS—autistic disorder	4.78e-06	8.2e-06	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—HRAS—autistic disorder	4.77e-06	8.18e-06	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—POMC—autistic disorder	4.76e-06	8.16e-06	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—MTHFR—autistic disorder	4.75e-06	8.14e-06	CbGpPWpGaD
Pazopanib—LCK—Disease—IL6—autistic disorder	4.72e-06	8.08e-06	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—PIK3CG—autistic disorder	4.71e-06	8.08e-06	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—IL6—autistic disorder	4.58e-06	7.85e-06	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—IL6—autistic disorder	4.57e-06	7.83e-06	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—COMT—autistic disorder	4.54e-06	7.77e-06	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—GSTP1—autistic disorder	4.52e-06	7.74e-06	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—MAOA—autistic disorder	4.5e-06	7.72e-06	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—POMC—autistic disorder	4.49e-06	7.69e-06	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—APOE—autistic disorder	4.42e-06	7.58e-06	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—CAT—autistic disorder	4.39e-06	7.53e-06	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—PTGS2—autistic disorder	4.36e-06	7.47e-06	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—HRAS—autistic disorder	4.3e-06	7.37e-06	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—MAPK1—autistic disorder	4.3e-06	7.36e-06	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—HRAS—autistic disorder	4.21e-06	7.21e-06	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—PLA2G4A—autistic disorder	4.15e-06	7.11e-06	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—GSTM1—autistic disorder	4.15e-06	7.11e-06	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—IL6—autistic disorder	4.12e-06	7.05e-06	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—IL6—autistic disorder	4.03e-06	6.9e-06	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—PIK3CG—autistic disorder	3.99e-06	6.84e-06	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—GPX1—autistic disorder	3.97e-06	6.81e-06	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—PTEN—autistic disorder	3.8e-06	6.51e-06	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—POMC—autistic disorder	3.8e-06	6.51e-06	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—PTGS2—autistic disorder	3.8e-06	6.51e-06	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—MTHFR—autistic disorder	3.67e-06	6.28e-06	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—PTGS2—autistic disorder	3.58e-06	6.13e-06	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—HRAS—autistic disorder	3.45e-06	5.91e-06	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—APOE—autistic disorder	3.41e-06	5.85e-06	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—PTEN—autistic disorder	3.31e-06	5.67e-06	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—IL6—autistic disorder	3.3e-06	5.66e-06	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—PTEN—autistic disorder	3.12e-06	5.35e-06	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—PIK3CG—autistic disorder	3.08e-06	5.28e-06	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—PTGS2—autistic disorder	3.03e-06	5.19e-06	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—POMC—autistic disorder	2.93e-06	5.03e-06	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—PTEN—autistic disorder	2.64e-06	4.53e-06	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—PTGS2—autistic disorder	2.34e-06	4.01e-06	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—PTEN—autistic disorder	2.04e-06	3.5e-06	CbGpPWpGaD
